Bank of America’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bank of America’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-100	Closed	-$10K	–	7657
2019 Q3	$10K	Buy	+100	New	+$10K	﹤0.01%	6729
2019 Q2	–	Sell	-1,100	Closed	-$125K	–	7587
2019 Q1	$125K	Sell	1,100 -48,900	-98%	-$3.59M	﹤0.01%	5757
2018 Q4	$1.96M	Hold	50,000	–	–	﹤0.01%	3860
2018 Q3	$2.73M	Buy	+50,000	New	+$3.42M	﹤0.01%	3720
2018 Q2	–	Sell	-95,200	Closed	-$6.34M	–	7473
2018 Q1	$6.34M	Buy	95,200 +73,400	+337%	+$4.24M	﹤0.01%	2853
2017 Q4	$1.12M	Sell	21,800 -8,200	-27%	-$589K	﹤0.01%	4409
2017 Q3	$2.67M	Buy	+30,000	New	+$2.28M	﹤0.01%	3747

Bank of America's ONCE Position: Q4 2019 in Review

Bank of America sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 100,827 shares — an estimated $9.78M sold.

Bank of America first reported a position in ONCE in Q1 2015 and held it in 19 quarters. The position peaked at $17.9M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Bank of America reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Bank of America sold 100,827 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $9.78M.
Bank of America first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 19 quarters.
Bank of America's Spark Therapeutics, Inc. Common Stock position peaked at $17.9M in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.